Illumina, Inc. (ILMN)

351.65
NASDAQ
Prev Close 347.28
Day Low/High 342.07 / 353.60
52 Wk Low/High 335.68 / 555.77
Exchange NASDAQ
Shares Outstanding 156.30B
Market Cap 54.28B
P/E Ratio 94.26
Div & Yield N.A. (N.A)
Illumina's Future Looks Very Bright

Illumina's Future Looks Very Bright

Charts show ILMN is close to offering a great profit opportunity.

Novice Trade: Illumina

Novice Trade: Illumina

ILMN's three-month at-the-money implied volatility is at about the median level.

Illumina Could Light Up; a Reversal Is in the Works

Illumina Could Light Up; a Reversal Is in the Works

With very low oversold readings and a possible reversal pattern, we would at least cover shorts, and would consider probing the long side.

Today's Takeaways and Observations (Monarch Notes Edition --- Because I Am Beat).

My thoughts on the day: The five-day market win streak stalled a bit today. Though the close was weak, I still give the win to the bulls because of the modest drop in the averages after an 80-handle rise in the S&P index. That said, there was less t...

Are Drug Stocks What's Ailing the Market?

Are Drug Stocks What's Ailing the Market?

This move in health care takes your breath away.

Jared Woodard Intermediate Trade: IBB

Jared Woodard Intermediate Trade: IBB

Take advantage of elevated option premiums to gain long exposure to biotech.

Illumina Plummets on Weak Sales Forecast; Biotech Stocks Fall

Illumina Plummets on Weak Sales Forecast; Biotech Stocks Fall

DNA sequencing company Illumina (ILMN) plummeted in midday trading Tuesday after reporting disappointing preliminary sales for its third quarter.

Illumina Dims, but It's Still Set Up to Shine

With such a commanding lead in the sequencing business the stock can't stay down for long.

Illumina downgraded at Leerink

Illumina added to Focus List at Citi

Apple, Microsoft Sink Stocks; Baker Hughes' Volatile Afternoon

Apple, Microsoft Sink Stocks; Baker Hughes' Volatile Afternoon

Apple (AAPL) and Microsoft (MSFT) dragged on benchmark indexes.

Market Wrap: IBM and United Tech a Real Drag

Market Wrap: IBM and United Tech a Real Drag

IBM and UTX accounted for two-thirds of the Dow's 1% drop, and Apple and Microsoft fall after-hours..

Market Is Showing Its Underlying Weakness

Market Is Showing Its Underlying Weakness

Indices haven't reflected stocks' overall health.

Bright Idea: Take Some Illumina Off The Table

Bright Idea: Take Some Illumina Off The Table

After a strong run for the maker of scientific tools, investors may be vulnerable to a correction.

Here Are 3 Charts Showing You Why Illumina Is a Marvel

Here Are 3 Charts Showing You Why Illumina Is a Marvel

It's almost impossible to get too excited about its success.

Can Biotechs' Relative Strength Be Trusted? 6 Stocks to Watch

Can Biotechs' Relative Strength Be Trusted? 6 Stocks to Watch

Sector may not be as bulletproof as we thought.

Momentum Is Not Dead

The chasing in certain areas was intense.

Those Sensitive Biotechs

They are prone to being whipsawed by news.

Stick With the Price Action

It's the only way to deal with this market.

The Power of Momentum Won

Trends have a great tendency to persist.

The Uptrend Is Back

And no one thinks it's going to be easy to navigate.

Illumina estimates, target raised at JMP

Illumina upgraded at Piper

Stay Far Away From These Hot Potatoes

Stay Far Away From These Hot Potatoes

Here are three stocks to avoid at current levels.

Illumina upgraded at Wedbush

Illumina upgraded at Maxim

That Was the Week That Was

That Was the Week That Was

Let's review.

Decoding Illumina (Part 2)

Decoding Illumina (Part 2)

I'd wait until the stock cools off to buy shares.

Decoding Illumina (Part 1)

Decoding Illumina (Part 1)

Its genetics work has the stock at crazy new heights